Recent Updates
Recently added Catalysts
BMRN Positive Sentiment

Hope for a Brighter Future: Kainen’s Story

Key Takeaway: Cathy's son, Kainen, was diagnosed with Duchenne muscular dystrophy after showing physical challenges. The family sought support from CureDuchenne, a nonprofit organization, which helped them connect with others and learn about managing the condition. They remain optimistic about future advancements in treatment that could enhance Kainen's mobility and quality of life.
Price reaction · baseline $84.08 (2024-09-06 close) · clean, no other BMRN news in the window
day 0 close · peak
+0.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Cathy and Marcus are hopeful about advancements in treatment.
  • The family connects with a supportive community through CureDuchenne.
  • Kainen's vibrant personality shines despite his diagnosis.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+25%
120-day peak, hindsight
Typical move
7.9%
average across 8 past catalysts
Lead asset
Valoctocogene roxaparvovec
Phase 3 · Hemophilia A

Full Press Release Details

Growing up, Cathy didn’t get to meet her uncle, who was wheelchair-bound and ultimately died of complications from Duchenne muscular dystrophy, a genetic condition characterized by progressive muscle degeneration and weakness.
But being familiar with his story, when Cathy’s son, Kainen, turned three and was experiencing physical challenges, she started to suspect something might be wrong.
“We decided to get Kainen checked out because he was having frequent falls, and then the toe-walking,” Cathy recalls. “If you’re toe-walking, it’s something that’s probably going on with your legs.”
At the local children’s hospital, Kainen underwent testing showing abnormally high serum creatine phosphokinase, or CPK, levels. Cathy and her family then underwent genetic testing. That testing ultimately confirmed Kainen’s diagnosis with Duchenne muscular dystrophy, and that Cathy was also a genetic carrier for the condition.
Cathy’s husband, Marcus, recalls receiving the news about his son’s diagnosis as emotional and difficult.
“ It was actually a dramatic change from that moment forward because it was doctor’s visit after doctor’s visit. ‘He can’t do this. He can’t do that,’” says Marcus. “And you look at him and you’re like, ‘Man, this the life of the party, and you’re telling me he has this issue?’ So, it was hard to accept.”
Cathy and Marcus connected with CureDuchenne , a nonprofit organization committed to improving the lives of everyone affected by Duchenne through research, patient care and innovation. The family began attending meetings and connecting with others in the Duchenne community. That experience helped them learn more about how to manage Kainen’s condition and provided inspiration.
Looking ahead, Cathy and Marcus are hopeful that advancements in treatment and care for people living with Duchenne will help enable Kainen to accomplish more.
“I just want him to have this ability to walk and be mobile,” says Marcus. “To be able to shine his light, you know? Just continue to have that fire that he has in him.”
• Topics:
• Community
• Duchenne
• Patients
• Rare Disease

Topics:

Frequently Asked Questions

What is Duchenne muscular dystrophy?

Duchenne muscular dystrophy is a genetic condition characterized by progressive muscle degeneration and weakness.

How was Kainen diagnosed?

Kainen was diagnosed after showing physical challenges and undergoing genetic testing that confirmed the condition.

What support did the family seek?

The family connected with CureDuchenne, a nonprofit focused on improving lives affected by Duchenne.

What are the parents' hopes for Kainen?

Cathy and Marcus hope for advancements in treatment that will help Kainen walk and be mobile.

Last updated: Sep 7, 2024